{"count": 8, "results": [{"_id": "32850203", "pmid": 32850203, "pmcid": "PMC7444850", "title": "A Case Report on Metformin-Associated Lactic Acidosis and Transient Blindness", "journal": "Cureus", "authors": ["Kalantri P", "Sahu A", "Kalantri A"], "date": "2020-07-21T00:00:00Z", "doi": "10.7759/cureus.9325", "meta_date_publication": "2020 Jul 21", "meta_volume": "12", "meta_issue": "7", "meta_pages": "e9325", "score": 50270.91, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ should be discontinued in all cases of @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@MALA@@@ and @<m>DISEASE_Vision_Disorders</m> @DISEASE_MESH:D014786 @@@vision loss@@@. ", "citations": {"NLM": "Kalantri P, Sahu A, Kalantri A. A Case Report on Metformin-Associated Lactic Acidosis and Transient Blindness Cureus. 2020 Jul 21;12(7):e9325. PMID: 32850203", "BibTeX": "@article{32850203, title={A Case Report on Metformin-Associated Lactic Acidosis and Transient Blindness}, author={Kalantri P and Sahu A and Kalantri A}, journal={Cureus}, volume={12}, number={7}, pages={e9325}}"}}, {"_id": "34437006", "pmid": 34437006, "pmcid": "PMC8143825", "title": "Reversible Total Vision Loss Caused by Severe Metformin-associated Lactic Acidosis: A Case Report", "journal": "Clin Pract Cases Emerg Med", "authors": ["Koons A", "Amaducci AM", "Katz KD"], "date": "2021-05-01T00:00:00Z", "doi": "10.5811/cpcem.2021.3.51141", "meta_date_publication": "2021 May", "meta_volume": "5", "meta_issue": "2", "meta_pages": "206-209", "score": 50259.137, "text_hl": "We present a case of a @SPECIES_9606 @@@patient@@@ whose serum @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ concentration was unusually high and associated with @<m>DISEASE_Vision_Disorders</m> @DISEASE_MESH:D014786 @@@vision loss@@@.", "citations": {"NLM": "Koons A, Amaducci AM, Katz KD. Reversible Total Vision Loss Caused by Severe Metformin-associated Lactic Acidosis: A Case Report Clin Pract Cases Emerg Med. 2021 May;5(2):206-209. PMID: 34437006", "BibTeX": "@article{34437006, title={Reversible Total Vision Loss Caused by Severe Metformin-associated Lactic Acidosis: A Case Report}, author={Koons A and Amaducci AM and Katz KD}, journal={Clin Pract Cases Emerg Med}, volume={5}, number={2}, pages={206-209}}"}}, {"_id": "40904364", "pmid": 40904364, "title": "Metformin may alter the course of Leber's hereditary optic neuropathy: a case report.", "journal": "Front Med (Lausanne)", "authors": ["Elmaseh SA", "Gauthier DA", "Golmohammadi M", "Pargalava N", "Carelli V", "Sadun AA"], "date": "2025-08-19T00:00:00Z", "doi": "10.3389/fmed.2025.1609941", "meta_date_publication": "2025", "meta_volume": "12", "meta_issue": "", "meta_pages": "1609941", "score": 50253.64, "text_hl": "In this study, we report the case of a 48-year-old @SPECIES_9606 @@@woman@@@ diagnosed with @DISEASE_Optic_Atrophy_Hereditary_Leber @DISEASE_MESH:D029242 @@@LHON@@@ (m.11778G>A/MT-ND4) and @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes mellitus@@@ who experienced visual field improvement following @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment after 26 months of progressive @<m>DISEASE_Vision_Disorders</m> @DISEASE_MESH:D014786 @@@vision loss@@@ unresponsive to @CHEMICAL_idebenone @CHEMICAL_MESH:C036619 @@@idebenone@@@, @CHEMICAL_NAD @CHEMICAL_MESH:D009243 @@@nicotinamide adenine dinucleotide@@@ (@CHEMICAL_NAD @CHEMICAL_MESH:D009243 @@@NAD+@@@), and hormone replacement therapy (HRT). ", "citations": {"NLM": "Elmaseh SA, Gauthier DA, Golmohammadi M, Pargalava N, Carelli V, Sadun AA. Metformin may alter the course of Leber's hereditary optic neuropathy: a case report. Front Med (Lausanne). 2025;12():1609941. PMID: 40904364", "BibTeX": "@article{40904364, title={Metformin may alter the course of Leber's hereditary optic neuropathy: a case report.}, author={Elmaseh SA and Gauthier DA and Golmohammadi M and Pargalava N and Carelli V and Sadun AA}, journal={Front Med (Lausanne)}, volume={12}, pages={1609941}}"}}, {"_id": "20627210", "pmid": 20627210, "title": "Transient vision loss in a patient with metformin-associated lactic acidosis.", "journal": "Am J Emerg Med", "authors": ["Kreshak AA", "Clark RF"], "date": "2010-11-01T00:00:00Z", "doi": "10.1016/j.ajem.2010.01.024", "meta_date_publication": "2010 Nov", "meta_volume": "28", "meta_issue": "9", "meta_pages": "1059.e5-7", "score": 50064.76, "text_hl": "Transient @<m>DISEASE_Vision_Disorders</m> @DISEASE_MESH:D014786 @@@vision loss@@@ in a @SPECIES_9606 @@@patient@@@ with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-associated @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@lactic acidosis@@@.", "citations": {"NLM": "Kreshak AA, Clark RF. Transient vision loss in a patient with metformin-associated lactic acidosis. Am J Emerg Med. 2010 Nov;28(9):1059.e5-7. PMID: 20627210", "BibTeX": "@article{20627210, title={Transient vision loss in a patient with metformin-associated lactic acidosis.}, author={Kreshak AA and Clark RF}, journal={Am J Emerg Med}, volume={28}, number={9}, pages={1059.e5-7}}"}}, {"_id": "21737421", "pmid": 21737421, "title": "Transient vision loss in a patient with severe metformin-associated lactic acidosis.", "journal": "QJM", "authors": ["Cigarrán S", "Rodriguez ML", "Pousa M", "Menéndez H", "Mendez MJ"], "date": "2012-08-01T00:00:00Z", "doi": "10.1093/qjmed/hcr109", "meta_date_publication": "2012 Aug", "meta_volume": "105", "meta_issue": "8", "meta_pages": "781-3", "score": 50062.92, "text_hl": "Transient @<m>DISEASE_Vision_Disorders</m> @DISEASE_MESH:D014786 @@@vision loss@@@ in a @SPECIES_9606 @@@patient@@@ with severe @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-associated @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@lactic acidosis@@@.", "citations": {"NLM": "Cigarrán S, Rodriguez ML, Pousa M, Menéndez H, Mendez MJ. Transient vision loss in a patient with severe metformin-associated lactic acidosis. QJM. 2012 Aug;105(8):781-3. PMID: 21737421", "BibTeX": "@article{21737421, title={Transient vision loss in a patient with severe metformin-associated lactic acidosis.}, author={Cigarrán S and Rodriguez ML and Pousa M and Menéndez H and Mendez MJ}, journal={QJM}, volume={105}, number={8}, pages={781-3}}"}}, {"_id": "25544946", "pmid": 25544946, "pmcid": "PMC4269085", "title": "Nonadherence and Contributing Factors among Ambulatory Patients with Antidiabetic Medications in Adama Referral Hospital", "journal": "J Diabetes Res", "authors": ["Gelaw BK", "Mohammed A", "Tegegne GT", "Defersha AD", "Fromsa M", "Tadesse E", "Gunasekaran T", "Ahmed M"], "date": "2014-01-01T00:00:00Z", "doi": "10.1155/2014/617041", "meta_date_publication": "2014", "meta_volume": "2014", "meta_issue": "", "meta_pages": "617041", "score": 50028.25, "text_hl": "Common comorbid conditions include @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@, 148 (54.82%), and @<m>DISEASE_Vision_Disorders</m> @DISEASE_MESH:D014786 @@@visual impairment@@@, 89 (32.96%). ", "citations": {"NLM": "Gelaw BK, Mohammed A, Tegegne GT, Defersha AD, Fromsa M, Tadesse E, Gunasekaran T, Ahmed M. Nonadherence and Contributing Factors among Ambulatory Patients with Antidiabetic Medications in Adama Referral Hospital J Diabetes Res. 2014;2014():617041. PMID: 25544946", "BibTeX": "@article{25544946, title={Nonadherence and Contributing Factors among Ambulatory Patients with Antidiabetic Medications in Adama Referral Hospital}, author={Gelaw BK and Mohammed A and Tegegne GT and Defersha AD and Fromsa M and Tadesse E and Gunasekaran T and Ahmed M}, journal={J Diabetes Res}, volume={2014}, pages={617041}}"}}, {"_id": "29103210", "pmid": 29103210, "title": "Insulin for the treatment of women with gestational diabetes.", "journal": "Cochrane Database Syst Rev", "authors": ["Brown J", "Grzeskowiak L", "Williamson K", "Downie MR", "Crowther CA"], "date": "2017-11-05T00:00:00Z", "doi": "10.1002/14651858.CD012037.pub2", "meta_date_publication": "2017 Nov 5", "meta_volume": "11", "meta_issue": "11", "meta_pages": "CD012037", "score": 50015.703, "text_hl": "There was no clear evidence of difference in postnatal weight retention between @SPECIES_9606 @@@women@@@ treated with @GENE_INS @GENE_3630 @@@insulin@@@ and those treated with oral anti-@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ pharmacological therapy (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@) at six to eight weeks postpartum (MD -1.60 kg, 95% CI -6.34 to 3.14; one study, 167 @SPECIES_9606 @@@women@@@; low-quality evidence) or one year postpartum (MD -3.70, 95% CI -8.50 to 1.10; one study, 176 @SPECIES_9606 @@@women@@@; low-quality evidence). ", "citations": {"NLM": "Brown J, Grzeskowiak L, Williamson K, Downie MR, Crowther CA. Insulin for the treatment of women with gestational diabetes. Cochrane Database Syst Rev. 2017 Nov 5;11(11):CD012037. PMID: 29103210", "BibTeX": "@article{29103210, title={Insulin for the treatment of women with gestational diabetes.}, author={Brown J and Grzeskowiak L and Williamson K and Downie MR and Crowther CA}, journal={Cochrane Database Syst Rev}, volume={11}, number={11}, pages={CD012037}}"}}, {"_id": "30592787", "pmid": 30592787, "title": "Alpha-glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.", "journal": "Cochrane Database Syst Rev", "authors": ["Moelands SV", "Lucassen PL", "Akkermans RP", "De Grauw WJ", "Van de Laar FA"], "date": "2018-12-28T00:00:00Z", "doi": "10.1002/14651858.CD005061.pub3", "meta_date_publication": "2018 Dec 28", "meta_volume": "12", "meta_issue": "12", "meta_pages": "CD005061", "score": 50013.78, "text_hl": "One trial with 90 @SPECIES_9606 @@@participants@@@ compared @CHEMICAL_Acarbose @CHEMICAL_MESH:D020909 @@@acarbose@@@ with diet and exercise and another trial with 98 @SPECIES_9606 @@@participants@@@ reported data on @CHEMICAL_Acarbose @CHEMICAL_MESH:D020909 @@@acarbose@@@ versus @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. There were no clear differences for any outcome measure between these two @CHEMICAL_Acarbose @CHEMICAL_MESH:D020909 @@@acarbose@@@ interventions and the associated comparator groups.None of the trials reported @DISEASE_Amputation_Congenital @DISEASE_MESH:C565682 @@@amputation of@@@ lower extremity, @DISEASE_Blindness @DISEASE_MESH:D001766 @@@blindness@@@ or severe @<m>DISEASE_Vision_Disorders</m> @DISEASE_MESH:D014786 @@@vision loss@@@, @DISEASE_Kidney_Failure_Chronic @DISEASE_MESH:D007676 @@@end-stage renal disease@@@, health-related quality of life, time to progression to @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2DM@@@, or socioeconomic effects. ", "citations": {"NLM": "Moelands SV, Lucassen PL, Akkermans RP, De Grauw WJ, Van de Laar FA. Alpha-glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database Syst Rev. 2018 Dec 28;12(12):CD005061. PMID: 30592787", "BibTeX": "@article{30592787, title={Alpha-glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.}, author={Moelands SV and Lucassen PL and Akkermans RP and De Grauw WJ and Van de Laar FA}, journal={Cochrane Database Syst Rev}, volume={12}, number={12}, pages={CD005061}}"}}]}